排序方式: 共有2条查询结果,搜索用时 15 毫秒
1
1.
The specialty of pain medicine, as noted by Lippe,“… justifies itself as a unique medical specialty by virtue of a distinct
body of knowledge and a well-defined scope of practice. In common with other medical specialties, it is founded on an infrastructure
of scientific research, education, and clinical practice [1].“ The traditional methods of education for healthcare providers,
such as medical schools, nursing schools, physical therapy schools, and clinical psychology programs, do not prepare their
students adequately for the delivery of evaluation and treatment services to patients experiencing pain. Also apparent, as
evidenced by the dearth of medical literature, is that the traditional methods of educating pain specialists do not adequately
prepare students for an effective approach to the realities of healthcare economics in their respective fields.The result
of a lack of significant education in the economics of pain medicine can be financially devastating to a new practitioner
who is practicing “good” medicine yet not meeting the financial obligations incipient in the operation of a multidisciplinary
pain center or even a solo practice. One important concept in the study of healthcare economics is the issue of cost-effectiveness
[2]. 相似文献
2.
S. Raj Sundaraj MBBS FANZCA FFPMANZCA FIPP CIME ; Paul Ponciano MD ; Charlotte Johnstone MBBS FANZCA FFPMANZCA ; Faiz Noore MBBS FANZCP FFPMANZCA ; Maria Castro RN CNC 《Pain practice》2004,4(3):229-234
Abstract: Chronic refractory daily headache is a relatively common problem in the Australian population. Several million working hours per year are lost due to this illness. Generally not responding to conventional therapies. We treated 22 such patients diagnosed as severe refractory migraine and/or mixed tension headache at our multidisciplinary pain management center. Before inclusion to our study, they received maximal medical management, which included cognitive behavior therapy, but failed to respond. These patients received between 30 and 100 units of botulinum toxin type A. Our study showed 84% (19 of 22) achieved significant improvement in their pain complaint. There was significant reduction of medications particularly opioids. The duration of pain relief ranged from 1 to 6 months. Repeat injections were necessary in several of the patients. There were minor complications but these reversed spontaneously without further treatment. 相似文献
1